The pathogenesis of CM is characterized by persistent up-regulation of Th1 cytokines and inadequate production of anti-inflammatory cytokines including IL-4 and IL-13, which could possibly account for the observed lower levels of IL-4 and IL-1334. This evidence concerns the gene IL4 and cutaneous mastocytosis.